Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes
Sean L. Zheng(Imperial College London), Karim Meeran(Imperial College Healthcare NHS Trust)
Cited by 406
Related Papers
Association between high serum total cortisol concentrations and mortality from COVID-19
|The Lancet Diabetes & Endocrinology|2020|260
Thyroid Function Before, During, and After COVID-19
|The Journal of Clinical Endocrinology & Metabolism|2020|220
Normal Adrenal and Thyroid Function in Patients Who Survive COVID-19 Infection
|The Journal of Clinical Endocrinology & Metabolism|2021|74